Kozo Kuribayashi
Hyogo Medical University · 169 works · 2,768 citations · h-index 23
Top works
- The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
- Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
- IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice
- Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma
- Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
- Allergic Bronchial Asthma: Airway Inflammation and Hyperresponsiveness
- Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells
- Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma
- Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
- Air pollution in the Asia‐Pacific Region
- Heme oxygenase‐1 (HO‐1) protein induction in a mouse model of asthma
- Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma
- Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases
- Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma
- Present and future roles of FDG-PET/CT imaging in the management of lung cancer
- Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
- First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma
- Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer